PMID
Cmpds
Data
Article Title
Organization
15
Variation of the aryl substituent on the piperazine ring within the 4-(piperazin-1-yl)-2,6-di(pyrrolidin-1-yl)pyrimidine scaffold unveils potent, non-competitive inhibitors of the inflammatory caspases.

Depaul University
13
Inhibiting the Inflammasome: A Chemical Perspective.

University of Manchester
3
Azaphilones from an Acid Mine Extremophile Strain of a Pleurostomophora sp.

Memorial Sloan-Kettering Cancer Center
2
Electrophilic warhead-based design of compounds preventing NLRP3 inflammasome-dependent pyroptosis.

University of Turin
29
Synthesis of 7-halogenated isatin sulfonamides: nonradioactive counterparts of caspase-3/-7 inhibitor-based potential radiopharmaceuticals for molecular imaging of apoptosis.

Westf£Lische Wilhelms-Universit£T M£Nster
15
Synthesis of new fluorinated, 2-substituted 5-pyrrolidinylsulfonyl isatin derivatives as caspase-3 and caspase-7 inhibitors: nonradioactive counterparts of putative PET-compatible apoptosis imaging agents.

Westf£Lische Wilhelms-Universit£T M£Nster
5
Irreversible inhibitors of cysteine proteases.

Dart Neuroscience
2
Caspase-1 and -3 inhibiting drimane sesquiterpenoids from the extremophilic fungus Penicillium solitum.

University of Montana
5
Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation.

University of Florida
10
Synthesis and evaluation of thiazepines as interleukin-1beta converting enzyme (ICE) inhibitors.

Procter and Gamble Pharmaceuticals
8
Discovery of novel conformationally restricted diazocan peptidomimetics as inhibitors of interleukin-1beta synthesis.

Procter & Gamble Pharmaceuticals
107
Protease inhibitors: current status and future prospects.

University of Queensland
16
Dipeptidyl aspartyl fluoromethylketones as potent caspase-3 inhibitors: SAR of the P2 amino acid.

Maxim Pharmaceuticals
13
Peptidyl beta-homo-aspartals: specific inhibitors of interleukin-1 beta converting enzyme and its homologues (caspases).

Institute For Drug Research
39
Synthesis and evaluation of isatin analogs as caspase-3 inhibitors: introduction of a hydrophilic group increases potency in a whole cell assay.

Washington University
42
Inhibition of interleukin-1beta converting enzyme (ICE or caspase 1) by aspartyl acyloxyalkyl ketones and aspartyl amidooxyalkyl ketones.

Pfizer
28
Succinic acid amides as P2-P3 replacements for inhibitors of interleukin-1beta converting enzyme (ICE or caspase 1).

Pfizer
12
Noncovalent tripeptidyl benzyl- and cyclohexyl-amine inhibitors of the cysteine protease caspase-1.

The University of Queensland
35
Identification and optimization of inhibitors of Trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB.

National Human Genome Research Institute
25
3-chloro-4-carboxamido-6-arylpyridazines as a non-peptide class of interleukin-1β converting enzyme inhibitor

TBA
13
Structure-based design of non-peptidic pyridone aldehydes as inhibitors of interleukin-1β converting enzyme

TBA
32
PYRIDONE-BASED PEPTIDOMIMETIC INHIBITORS OF INTERLEUKIN-1β-CONVERTING ENZYME (ICE)

TBA
2
Structural and stereochemical requirements of time-dependent inactivators of the interleukin-1β converting enzyme

TBA
18
Inhibition of interleukin-1β converting enzyme by N-acyl-aspartyl aryloxymethyl ketones

TBA
16
Inhibition of interleukin-1β converting enzyme by N-Acyl-aspartic acid ketones

TBA
17
The synthesis and evaluation of peptidyl aspartyl aldehydes as inhibitors of ice.

TBA
8
Activated ketones as potent reversible inhibitors of interleukin-Iβ converting enzyme

TBA
2
Synthesis of a peptidyl 2,2-difluoro-4-phenylbutyl ketone and its evaluation as an inhibitor of interleukin-1β converting enzyme.

TBA
9
Phenylalkyl ketones as potent reversible inhibitors of interleukin-1β converting enzyme

TBA
1
Synthesis of a potent, reversible inhibitor of interleukin-1β converting enzyme

TBA
21
Fluorinated isatin derivatives. Part 2. New N-substituted 5-pyrrolidinylsulfonyl isatins as potential tools for molecular imaging of caspases in apoptosis.

Westfalische Wilhelms-Universitat
14
Design, synthesis, and biological characterization of a caspase 3/7 selective isatin labeled with 2-[18F]fluoroethylazide.

Imperial College
39
Recent developments in fragment-based drug discovery.

Astex Therapeutics
2
The berkeleyamides, amides from the acid lake fungus Penicillum rubrum.

Montana Tech of The University of Montana
24
Discovery of a Covalent Inhibitor of Pro-Caspase-1 Zymogen Blocking NLRP3 Inflammasome Activation and Pyroptosis.

Chinese Academy of Sciences
56
Interleukin-1β converting enzyme (ICE): A comprehensive review on discovery and development of caspase-1 inhibitors.

L J University Ahmedabad
18
Dipeptidyl aspartyl fluoromethylketones as potent caspase inhibitors: peptidomimetic replacement of the P(2) amino acid by 2-aminoaryl acids and other non-natural amino acids.

Epicept
13
Isatin sulfonamide analogs containing a Michael addition acceptor: a new class of caspase 3/7 inhibitors.

Washington University
7
Solid-phase analogue synthesis of caspase-3 inhibitors via palladium-catalyzed amination of 3-bromopyrazinones.

Merck Frosst Centre For Therapeutic Research
5
Synthesis of novel caspase inhibitors for characterization of the active caspase proteome in vitro and in vivo.

University of Edinburgh
20
5-pyrrolidinylsulfonyl isatins as a potential tool for the molecular imaging of caspases in apoptosis.

University Hospital of The WestfäLische Wilhelms-UniversitäT
23
Synthesis and evaluation of unsaturated caprolactams as interleukin-1beta converting enzyme (ICE) inhibitors.

Procter & Gamble Pharmaceuticals
68
Furazans in Medicinal Chemistry.

Treventis
1
Synthesis, radiolabeling, and in vivo evaluation of an 18F-labeled isatin analog for imaging caspase-3 activation in apoptosis.

Washington University
22
Synthesis and evaluation of novel 1-(2-acylhydrazinocarbonyl)-cycloalkyl carboxamides as interleukin-1beta converting enzyme (ICE) inhibitors.

Procter & Gamble Pharmaceuticals
17
Design, synthesis and biological evaluation of 1,5-disubstituted α-amino tetrazole derivatives as non-covalent inflammasome-caspase-1 complex inhibitors with potential application against immune and inflammatory disorders.

National Research Council (Cnr)
29
Tethering identifies fragment that yields potent inhibitors of human caspase-1.

Sunesis Pharmaceuticals
29
Synthesis and evaluation of novel 8,6-fused bicyclic peptidomimetic compounds as interleukin-1beta converting enzyme inhibitors.

Procter & Gamble Pharmaceuticals
6
Synthesis and evaluation of tricyclic pyrrolopyrimidinones as dipeptide mimetics: inhibition of interleukin-1beta-converting enzyme.

Procter & Gamble Pharmaceuticals
50
Novel pyrazinone mono-amides as potent and reversible caspase-3 inhibitors.

Merck Frosst Centre For Therapeutic Research
33
Discovery of a Series of Pyrimidine Carboxamides as Inhibitors of Vanin-1.

Pfizer
3
Oxamyl dipeptide caspase inhibitors developed for the treatment of stroke.

Idun Pharmaceuticals
1
Cannabidiol Protects Human Skin Keratinocytes from Hydrogen-Peroxide-Induced Oxidative Stress via Modulation of the Caspase-1-IL-1β Axis.

University of Rhode Island
15
The design and synthesis of sulfonamides as caspase-1 inhibitors.

Pfizer
3
Structure-activity relationships within a series of caspase inhibitors: effect of leaving group modifications.

Idun Pharmaceuticals
17
Structure-activity relationship study and drug profile of N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal (SJA6017) as a potent calpain inhibitor.

Senju Pharmaceutical
20
Acyl dipeptides as reversible caspase inhibitors. Part 2: further optimization.

Idun Pharmaceuticals
51
Acyl dipeptides as reversible caspase inhibitors. Part 1: initial lead optimization.

Idun Pharmaceuticals
1
A practical synthesis of (S) 3-tert-butoxycarbonylamino-2-oxo-2,3,4,5-tetrahydro-1,5-benzodiazepine-1-acetic acid methyl ester as a conformationally restricted dipeptido-mimetic for caspase-1 (ICE) inhibitors.

Vertex Pharmaceuticals
35
Caspases as targets for anti-inflammatory and anti-apoptotic drug discovery.

Basf Bioresearch
15
Conformationally constrained inhibitors of caspase-1 (interleukin-1 beta converting enzyme) and of the human CED-3 homologue caspase-3 (CPP32, apopain).

Idun Pharmaceuticals
5
Rapid optimization of an ICE inhibitor synthesis using multiple reaction conditions in a parallel array.

Warner-Lambert
1
Novel cytokine release inhibitors. Part I: Triterpenes.

RhóNe-Poulenc Rorer Central Research
30
Peptidomimetic aminomethylene ketone inhibitors of interleukin-1 beta-converting enzyme (ICE).

Ferring Research Institute
6
Pyridazinodiazepines as a high-affinity, P2-P3 peptidomimetic class of interleukin-1 beta-converting enzyme inhibitor.

Sanofi Winthrop
3
New Caspase-1 inhibitor by scaffold hopping into bio-inspired 3D-fragment space.

Edelris
23
Rational Drug Design of Topically Administered Caspase 1 Inhibitors for the Treatment of Inflammatory Acne.

Nestle Skin Health
98
Pyrimidine TBK/IKKe inhibitor compounds and uses thereof

Merck Patent
5
Organic compounds

Intra-Cellular Therapies
190
1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors

H. Lundbeck
20
3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2,7-dione compounds for the treatment and prophylaxis of virus infection

Hoffmann-La Roche
210
Tricyclic PI3K inhibitor compounds and methods of use

Genentech
2
Evolution of Src Homology 2 (SH2) Domain to Recognize Sulfotyrosine.

University of Nebraska-Lincoln
13
N-[9-(ortho-fluorobenzyl)-2-phenyl-8-azapurin-6-yl]-amides as potent and selective ligands for A1 adenosine receptors.

University of Pisa
12
Novel amidino-substituted benzimidazoles: synthesis of compounds and inhibition of dipeptidyl peptidase III.

The Josip Juraj Strossmayer University
17
The 5-HT7 receptor: orphan found.

Roche Bioscience
20
Synthesis and biological evaluation of phenolic Mannich bases of benzaldehyde and (thio)semicarbazone derivatives against the cysteine protease falcipain-2 and a chloroquine resistant strain of Plasmodium falciparum.

University of Cape Town
36
Piperazine derivatives for treating disorders

The University of Nottingham
7
Methods of treating retroviral infections and related dosage regimes

Chimerix
21
Novel Indolocarbazole protein kinase C inhibitors with improved biochemical and physicochemical properties.

Tumor Biology Center
25
4,1-Benzoxazepinone analogues of efavirenz (Sustiva) as HIV-1 reverse transcriptase inhibitors.

Dupont Pharmaceuticals
29
Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitors.

Dupont Pharmaceuticals